{"disease":{"id":"nf1-mutation-positive-malignant-peripheral-nerve-sheath-tumor","name":"nf1 mutation positive malignant peripheral nerve sheath tumor"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03872427","title":"Testing Whether Cancers With Specific Mutations Respond Better to Glutaminase Inhibitor, Telaglenastat Hydrochloride, Anti-Cancer Treatment, BeGIN Study","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":54,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}